Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
Cannabidiol Market Size 2023-2030: Global Analysis by Type, Product, Sales, Region, Competitive Landscape, End-Use Outlook, Overview, Supply and Demand Side Analysis
April 24, 2023 15:34 ET
|
Delvens
City of Boardman, April 24, 2023 (GLOBE NEWSWIRE) -- The global market for Cannabidiol is expected to reach $4.14 billion by 2030 from $1.92 billion in 2021, registering impressive expansion at a...
Incannex Appoints QPS to Advance CannQuit-N™ (Nicotine), CannQuit-O™ (Opioid) and Renecann™ Products in the USA and EU
April 14, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, April 14, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Ltd (Nasdaq: IXHL) (ASX: IHL) (‘Incannex’ or ‘the Company’) a pharmaceutical company developing proprietary medicinal...
Prati-Donaduzzi Secures the Largest Global Pharma Supply Agreement for Natural Cannabinoids with API Manufacturer Brains Bioceutical
April 04, 2023 01:00 ET
|
Brains Bioceutical Corp
VANCOUVER, British Columbia, April 04, 2023 (GLOBE NEWSWIRE) -- Brains Bioceutical Corp (“Brains Bio” or the “Company”), the largest natural cannabinoid active pharmaceutical ingredient (“API”)...
CBD Gummies Market Size ($12.18 Billion) Growth Forecasts at 28.3% of CAGR during 2021 to 2028 – Global Analysis by The Insight Partners
January 31, 2023 09:55 ET
|
The Insight Partners
New York, Jan. 31, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “CBD Gummies Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Cannabidiol Oil (CBD Oil) Market is expected to grow at a CAGR of 38.90% & is Expected to cross USD 136.64 Billion by year 2030 | Data by Contrive Datum Insights Pvt Ltd.
January 09, 2023 07:11 ET
|
Contrive Datum Insights Pvt Ltd
Farmington, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The global Cannabidiol Oil (CBD Oil) Market is expected to at a CAGR of 38.90% during the forecast period. This indicates that the market value, which...
$23.2+ Billion Worldwide Cannabidiol Industry to 2031 - Rising Acceptance and Use of CBD Products Due to Government Approvals Drives Growth
January 06, 2023 04:18 ET
|
Research and Markets
Dublin, Jan. 06, 2023 (GLOBE NEWSWIRE) -- The "Cannabidiol Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
Vantage Hemp Co. Looks Ahead to 2023 After a Breakout Year in International Markets and New Industries
December 15, 2022 08:30 ET
|
Vantage Hemp
Greeley, Colorado, Dec. 15, 2022 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or the “Company”), has continued to stand out in an ever-changing CBD industry through an unrelenting commitment to...